Evidence map›Paper›PMID 34069172›Full record

ArticleInternational journal of environmental research and public health2021

Epidemiological Aspects of the Initial Evolution of COVID-19 in Microregion of Uberlândia, Minas Gerais (MG), Brazil.

Deborah Araujo Policarpo, Eduarda Cristina Alves Lourenzatto, Talita Costa E Silva Brito, Daise Aparecida Rossi, Roberta Torres de Melo

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Deborah Araujo PolicarpoLaboratório de Epidemiologia Molecular, Faculdade de Medicina Veterinária, Universidade Federal de Uberlândia, Uberlândia 38400-000, Brazil.
Eduarda Cristina Alves LourenzattoLaboratório de Epidemiologia Molecular, Instituto de Biologia, Universidade Federal de Uberlândia, Uberlândia 38400-000, Brazil.
Talita Costa E Silva BritoSuperintendência Regional de Saúde, Setor de Vigilância em Saúde da Macrorregião de Uberlândia, Uberlândia 38400-000, Brazil.
Daise Aparecida RossiLaboratório de Biotecnologia Animal e Aplicada, Faculdade de Medicina Veterinária, Universidade Federal de Uberlândia, Uberlândia 38400-000, Brazil.ORCID 0000-0003-2003-696X
Roberta Torres de MeloLaboratório de Epidemiologia Molecular, Faculdade de Medicina Veterinária, Universidade Federal de Uberlândia, Uberlândia 38400-000, Brazil.ORCID 0000-0001-8265-5163

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 is considered by the World Health Organization to be a global public health emergency, which presents regional divergences that affect the epidemiological profile of the disease and are associated with political, economic, social and behavioral aspects. We aimed to analyze the epidemiological characteristics of the disease in the microregion of Uberlândia, Brazil, in order to determine risk factors that contributed to progression of SARS-CoV-2 virus. A cross-sectional study was conducted about micro- and macro-determinants combined with the significance analysis of suspected and confirmed cases in 18 municipalities during the epidemiological weeks (EW) 9 to 26. There were 34,046 notifications, of which 4935 (14.49%) people were diagnosed with COVID-19. Of these, 282 (5.71%) required hospital care and 40 (0.81%) died. Age and presence of associated comorbidities were decisive in the variations of incidence and lethality rates. In general, young people were the most affected and the elderly people, the most exposed to the serious and lethal form (

Indexed as

COVID-19AdolescentAgedBrazilCitiesCross-Sectional StudiesHumansSARS-CoV-2COVID-19epidemiologic studiesincidencemultimorbiditySARS-CoV-2

Identifiers

PMID34069172
PMCPMC8157100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.